Prospective cross-sectional study of tuberculosis screening in United Arab Emirates

被引:8
作者
Almarzooqi, Farida [1 ]
Alkhemeiri, Aysha [2 ]
Aljaberi, Ahmed [2 ]
Hashmey, Rayhan [2 ]
Zoubeidi, Taoufik [3 ]
Souid, Abdul-Kader [1 ]
机构
[1] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates
[2] Tawam Hosp, Dept Med, Al Ain, U Arab Emirates
[3] UAE Univ, Dept Stat, Al Ain, U Arab Emirates
关键词
TB screening; Latent TB infection; TB disease; United Arab Emirates; Gulf region; Interferon-gamma release assay; ABU-DHABI; INFECTION;
D O I
10.1016/j.ijid.2018.03.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Intense migrations from tuberculosis endemic areas to Gulf countries create special risks for people in the region. The purpose of this study was to provide data that could justify implementing universal, regular TB screening in UAE. Design: This prospective, cross-sectional study used interferon-gamma release assay (IGRA) to screen for TB among Emirati citizens between August-2016 and May-2017; expatriates were not included in this study. Participants were recruited from Emiratis attending Tawam Hospital Polyclinics for problems unrelated to TB risk assessment. IGRA was requested for all enrolled participants. A risk-assessment questionnaire was completed by all participants. In addition, a retrospective review of IGRA results (January-2011 to April-2016) was conducted to compare prevalence of positive IGRA in the 'prospective sample' with that in 'patients screened in the past'. Results: Four hundred fifty-five participants (69% females) were enrolled in this study. Participants' age (mean +/- SD) was 42 +/- 16y. The majority of participants had traveled to or had helpers from TB-endemic areas. Two hundred forty (53%) participants had IGRA test. Forty-five (18.8%) participants had positive IGRA, similar to the retrospective results of 12.4% to 23.5%. Conclusions: The prevalence of positive-IGRA in this study is high. (C) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 21 条
  • [1] Updates on the risk factors for latent tuberculosis reactivation and their managements
    Ai, Jing-Wen
    Ruan, Qiao-Ling
    Liu, Qi-Hui
    Zhang, Wen-Hong
    [J]. EMERGING MICROBES & INFECTIONS, 2016, 5
  • [2] Prevalence of pulmonary tuberculosis among expatriates subjected to medical visa screening in Abu Dhabi, United Arab Emirates
    Al Hosani F.I.
    Yahia G.A.
    [J]. Journal of Epidemiology and Global Health, 2013, 3 (1) : 23 - 30
  • [3] Saudi guidelines for testing and treatment of latent tuberculosis infection
    Al Jahdali, Hamdan H.
    Baharoon, Salim
    Abba, Abdullah A.
    Memish, Ziad A.
    Alrajhi, Abdulrahman A.
    AlBarrak, Ali
    Haddad, Qais A.
    Al Hajjaj, Mohammad
    Pai, Madhukar
    Menzies, Dick
    [J]. ANNALS OF SAUDI MEDICINE, 2010, 30 (01) : 38 - 49
  • [4] The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi
    Al Mekaini, Lolowa A.
    Al Jabri, Omar N.
    Narchi, Hassib
    Kamal, Salwa M.
    Mabrook, Abdelazim
    Al Kuwaiti, Mariam M.
    Sheek-Hussein, Mohamud M.
    Souid, Abdul-Kader
    Alsuwaidi, Ahmed R.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 23 : 4 - 7
  • [5] Al-Zarouni M, 2010, SE ASIAN J TROP MED, V41, P163
  • [7] [Anonymous], 2015, GUID MAN LAT TUB INF
  • [8] [Anonymous], 2017, GLOB TUB REP
  • [9] Screening for Latent Tuberculosis Infection in Adults US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    Grossman, David C.
    Curry, Susan J.
    Bauman, Linda
    Davidson, Karina W.
    Epling, John W., Jr.
    Garcia, Francisco A. R.
    Herzstein, Jessica
    Kemper, Alex R.
    Krist, Alex H.
    Kurth, Ann E.
    Landefeld, Seth
    Mangione, Carol M.
    Phillips, William R.
    Phipps, Maureen G.
    Pignone, Michael P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 962 - 969
  • [10] Center for Disease Control and Prevention, 2016, TUB RISK FACT